Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2018
In Vitro Models to Study Influenza Virus and Staphylococcus aureus Super-Infection on a Molecular LevelChristin Bruchhagen, Andre van Krüchten, Carolin Klemm, et al.
Cell Communication and Signaling : CCS|May 22, 2024
Conversion of dendritic cells into tolerogenic or inflammatory cells depends on the activation threshold and kinetics of the mTOR signaling pathwayViktor Wixler, Yvonne Boergeling, Rafael Leite Dantas, et al.
Biomolecules|April 27, 2024
Small Spleen Peptides (SSPs) Shape Dendritic Cell Differentiation through Modulation of Extracellular ATP Synthesis ProfileViktor Wixler, Rafael Leite Dantas, Georg Varga, et al.
Optics Express|September 13, 2019
Image reconstruction and enhancement by deconvolution in scatter-plate microscopyStephan Ludwig, Benjamin Le Teurnier, Giancarlo Pedrini, et al.
Virology|January 25, 2011
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factorsPaulina Blazejewska, Lukasz Koscinski, Nuno Viegas, et al.
Pharmaceutics|September 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 DrugsAndré Schreiber, Benjamin Ambrosy, Oliver Planz, et al.
Cellular Microbiology|November 12, 2019
Type I interferon antagonistic properties of influenza B virus polymerase proteinsAndré Schreiber, Swantje Liedmann, Linda Brunotte, et al.
International Journal of Molecular Sciences|June 2, 2021
Altered Signal Transduction in the Immune Response to Influenza Virus and <i>S. pneumoniae</i> or <i>S. aureus</i> Co-InfectionsJanine J Wilden, Jasmin C Jacob, Christina Ehrhardt, et al.
Cellular Microbiology|January 10, 2008
The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 proteinIgor Mazur, Darisuren Anhlan, David Mitzner, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 25, 2026
Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistanceAndré Schreiber, Benjamin Ambrosy, Darisuren Anhlan, et al.
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
Methods in Molecular Biology (Clifton, N.J.)|August 29, 2018
In Vitro Models to Study Influenza Virus and Staphylococcus aureus Super-Infection on a Molecular LevelChristin Bruchhagen, Andre van Krüchten, Carolin Klemm, et al.
Cell Communication and Signaling : CCS|May 22, 2024
Conversion of dendritic cells into tolerogenic or inflammatory cells depends on the activation threshold and kinetics of the mTOR signaling pathwayViktor Wixler, Yvonne Boergeling, Rafael Leite Dantas, et al.
Biomolecules|April 27, 2024
Small Spleen Peptides (SSPs) Shape Dendritic Cell Differentiation through Modulation of Extracellular ATP Synthesis ProfileViktor Wixler, Rafael Leite Dantas, Georg Varga, et al.
Optics Express|September 13, 2019
Image reconstruction and enhancement by deconvolution in scatter-plate microscopyStephan Ludwig, Benjamin Le Teurnier, Giancarlo Pedrini, et al.
Virology|January 25, 2011
Pathogenicity of different PR8 influenza A virus variants in mice is determined by both viral and host factorsPaulina Blazejewska, Lukasz Koscinski, Nuno Viegas, et al.
Pharmaceutics|September 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 DrugsAndré Schreiber, Benjamin Ambrosy, Oliver Planz, et al.
Cellular Microbiology|November 12, 2019
Type I interferon antagonistic properties of influenza B virus polymerase proteinsAndré Schreiber, Swantje Liedmann, Linda Brunotte, et al.
International Journal of Molecular Sciences|June 2, 2021
Altered Signal Transduction in the Immune Response to Influenza Virus and <i>S. pneumoniae</i> or <i>S. aureus</i> Co-InfectionsJanine J Wilden, Jasmin C Jacob, Christina Ehrhardt, et al.
Cellular Microbiology|January 10, 2008
The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 proteinIgor Mazur, Darisuren Anhlan, David Mitzner, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 25, 2026
Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistanceAndré Schreiber, Benjamin Ambrosy, Darisuren Anhlan, et al.
Pageof 24